About HS Code 240492
This category covers nicotine products intended for transdermal application, primarily nicotine patches used for smoking cessation. These are pharmaceutical products, often classified as nicotine replacement therapy (NRT), and their trade is heavily influenced by healthcare regulations and public health initiatives. Manufacturers are typically pharmaceutical companies, and trade flows from production hubs to countries with established healthcare systems and consumer demand for NRTs. The global market for these products is stable, driven by ongoing efforts to reduce smoking rates. Quality control, clinical efficacy, and regulatory approvals (e.g., FDA, EMA) are paramount in the international trade of transdermal nicotine products, ensuring patient safety and product effectiveness.
Products Under This Code
Nicotine patches, transdermal nicotine systems, smoking cessation patches, extended-release nicotine patches, medicated nicotine patches
Real World Examples
Nicoderm CQ, Habitrol Patch, NicoDerm Patch, Equate Nicotine Patch, generic nicotine patches
Common Misclassification
This code is distinct from other nicotine delivery methods like oral (240491) or inhalation (240412), as it specifically targets transdermal absorption, often for therapeutic purposes.
Products Classified Under 2404.92
Industry
This code belongs to the Food & Beverages industry.
Trade Overview
Developed countries with strong healthcare systems are primary importers, while pharmaceutical hubs in Europe and North America are key exporters.
Frequently Asked Questions
What is HS code 240492?
HS code 240492 covers: Products n.e.c. in heading 2404, intended for the intake of nicotine into the human body, for transdermal application. This category covers nicotine products intended for transdermal application, primarily nicotine patches used for smoking cessation. These are pharmaceutical products, often classified as nicotine replacement therapy (NRT), and their trade is heavily influenced by healthcare regulations and public health initiatives. Manufacturers are typically pharmaceutical companies, and trade flows from production hubs to countries with established healthcare systems and consumer demand for NRTs. The global market for these products is stable, driven by ongoing efforts to reduce smoking rates. Quality control, clinical efficacy, and regulatory approvals (e.g., FDA, EMA) are paramount in the international trade of transdermal nicotine products, ensuring patient safety and product effectiveness.
What products fall under HS code 240492?
Nicotine patches, transdermal nicotine systems, smoking cessation patches, extended-release nicotine patches, medicated nicotine patches
What are common misclassifications for HS code 240492?
This code is distinct from other nicotine delivery methods like oral (240491) or inhalation (240412), as it specifically targets transdermal absorption, often for therapeutic purposes.
How is HS code 240492 structured?
HS code 240492 is a 6-digit subheading under the Harmonized System. The first 2 digits (24) identify the chapter, digits 3-4 (04) identify the heading, and digits 5-6 (92) specify the subheading. This code is standardized globally by the World Customs Organization.